Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents

Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii90-3. doi: 10.1136/ard.62.suppl_2.ii90.
No abstract available

Publication types

  • Review

MeSH terms

  • Antirheumatic Agents / chemistry
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Drug Design
  • Humans
  • Molecular Weight
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha